• Journal of Innovative Optical Health Sciences
  • Vol. 15, Issue 6, 2250035 (2022)
Yiming Zhou1、∥, Wenlong Zeng1、∥, Mengxuan Wang1、∥, Rui Li1, Xiuli Yue2、*, and Zhifei Dai1、**
Author Affiliations
  • 1Department of Biomedical Engineering, College of Future Technology, Peking University, Beijing 100871, P. R. China
  • 2School of Environment, Harbin Institute of Technology, Harbin 150001, P. R. China
  • show less
    DOI: 10.1142/S1793545822500353 Cite this Article
    Yiming Zhou, Wenlong Zeng, Mengxuan Wang, Rui Li, Xiuli Yue, Zhifei Dai. Ultrasmall pH-responsive silicon phthalocyanine micelle for selective photodynamic therapy against tumor[J]. Journal of Innovative Optical Health Sciences, 2022, 15(6): 2250035 Copy Citation Text show less

    Abstract

    Targeted photodynamic therapy (TPDT) based on the photosensitizers responsive for tumor microenvironment is promising because of the better anti-tumor effect and less phototoxicity against normal tissue than the traditional PDT. Nanoparticle-based stimuli-responsive photosensitizers have been widely explored for TPDT. Based on the acidic microenvironments in solid tumors, an ultrasmall pH-responsive silicon phthalocyanine nanomicelle (PSN) (smaller than 10nm) was designed for selective PDT of tumor. PSN had high drug loading efficacy (more than 28%) and exhibited morphological transitions, enhanced fluorescence and improved singlet oxygen yield under acidic environments. PSN was renal clearable and could rapidly accumulate and be retained at tumor sites, achieving a tumor-inhibiting effect better than phthalocyanine micelle without pH response. Tumors of mice treated with PSN for PDT were completely ablated without recurrence. Thus, we have developed a phthalocyanine-based pH-responsive micelle with excellent tumor targeting ability, which is expected to realize the selective PDT of tumor.Targeted photodynamic therapy (TPDT) based on the photosensitizers responsive for tumor microenvironment is promising because of the better anti-tumor effect and less phototoxicity against normal tissue than the traditional PDT. Nanoparticle-based stimuli-responsive photosensitizers have been widely explored for TPDT. Based on the acidic microenvironments in solid tumors, an ultrasmall pH-responsive silicon phthalocyanine nanomicelle (PSN) (smaller than 10nm) was designed for selective PDT of tumor. PSN had high drug loading efficacy (more than 28%) and exhibited morphological transitions, enhanced fluorescence and improved singlet oxygen yield under acidic environments. PSN was renal clearable and could rapidly accumulate and be retained at tumor sites, achieving a tumor-inhibiting effect better than phthalocyanine micelle without pH response. Tumors of mice treated with PSN for PDT were completely ablated without recurrence. Thus, we have developed a phthalocyanine-based pH-responsive micelle with excellent tumor targeting ability, which is expected to realize the selective PDT of tumor.